INSIGHTS ON QUALITY ASSURANCE
-
Robust Database Characterizes And Optimizes Product Development
Integrating material characterization data with process parameters accelerates drug development, reduces empirical testing, and strengthens regulatory compliance.
-
Ensure Sterility In Small-Batch Drug Production
Automation and sterility are critical for small-batch drug manufacturing. Learn how robotic isolators streamline vial filling, reduce contamination risk, and support advanced therapies with precision.
-
Ensuring Compliance For Virtual And Hybrid Pharmaceutical Companies
Proactive, risk-based oversight must be established to manage outsourced GXP activities. This requires a robust QMS and comprehensive quality agreements to safeguard product quality and data integrity.
-
The Benefits Of Low Endotoxin Products
Minimizing endotoxin contamination is vital in manufacturing to protect patients. Learn more about rigorously tested, low-endotoxin products designed for critical cleanroom and sterile applications.
-
Ensure Consistency Across Batches With A Powerful Tool5/19/2025
Learn how to streamline bioprocess control with an innovative software's Unit Save and Load feature. Save configurations, reduce setup time, and ensure consistency across batches with this powerful tool.
-
Cambrex Scientist Spotlight: Luigi Bellone1/29/2025
Luigi Bellone, Head of Quality Assurance in Paullo, Milan, brings over 20 years of experience in quality assurance (QA), quality control (QC), and regulatory compliance within the pharmaceutical industry.
-
GMP Twins: Making Digital Twins Real In GxP Manufacturing11/12/2025
True digital twins are redefining pharmaceutical manufacturing. Learn key distinctions, GMP-aligned frameworks, and real-world applications in predictive quality, CPV, and intelligent optimization.
-
Product-Wet Integrity Testing: Risk-Based Strategies5/22/2026
When standard water‑based integrity testing falls short, product‑wet approaches can offer a more representative alternative. Learn how risk‑based strategies are used to establish reliable test limits.
-
503A Vs. 503B: Turning Regulatory Complexity Into Practical Compliance4/20/2026
Navigating human drug compounding requires aligning Section 503A and Section 503B operations with cGMP expectations, robust quality management systems, and standing inspection readiness.
QUALITY ASSURANCE SOLUTIONS
-
Used Perkin Elmer Paragon 1000 PC FT-IR Spectrometer, benchtop design, serial# 38716.
-
A better approach to freeze-drying minimizes product loss, contamination risk, and downtime. Discover enclosed, single-use systems that support efficient sublimation while protecting sensitive materials.
-
As the time, costs and complexity of cleaning validation challenges grow, savvy life sciences companies are building a competitive advantage around smarter approaches to cleaning validation.
-
Explore the latest in contaminant detection technology with this pharmaceutical metal detector for tablets and capsules. Ensure the highest quality products with its failsafe rejection system and more.
-
Equipment changes, maintenance, and regulatory updates can quietly put compliance at risk. Learn how a lifecycle-based approach to qualification helps maintain performance and inspection readiness.